LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY: Gemtuzumab ozogamicin in AML. (2020). Mediterranean Journal of Hematology and Infectious Diseases, 12(1), e2020020. https://doi.org/10.4084/mjhid.2020.020